Overexpression of EGFR resulted in an increased expression of stem-cell marker, CD44, Oct-4, and Nanog 29, so EGFR inhibition might be an effective method to target the CSC populations in HNSCC. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.